ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 625–636 of 2020 project topics
Haplotype-Resolved Genome Assembly for Clinical Diagnostics
Commercial platforms leverage long reads to construct complete, phase-separated haplotype assemblies that enable precise identification of disease-causing variants in both alleles simultaneously. This capability commands premium pricing in prenatal diagnostics, rare disease identification, and pharmacogenomics reporting services.
Long Read Sequencing in Genetics Click to view more details →
Real-Time Pathogen Detection via Nanopore Sequencing Devices
Portable long-read sequencing systems with cloud-integrated analytics deliver pathogen identification within hours for clinical microbiology labs and point-of-care settings. Revenue streams include hardware licensing, consumable cartridges, and subscription-based bioinformatics analysis pipelines.
Long Read Sequencing in Genetics Click to view more details →
Gene Fusion and Oncogenic Rearrangement Detection Platform
SaaS-based tools process long-read sequencing data to comprehensively identify gene fusions, splice variants, and oncogenic rearrangements for cancer genomics laboratories and precision oncology centers. Service revenues derive from per-sample analysis fees and institutional licensing agreements with hospital systems.
Long Read Sequencing in Genetics Click to view more details →
Polyploid and Aneuploidy Characterization Commercial Suite
Proprietary algorithms quantify copy number variations, ploidy levels, and chromosomal imbalances using long-read data for agricultural genomics, cancer research, and developmental biology applications. Commercial models include tiered licensing tiers and white-label integration into third-party genomics platforms.
Long Read Sequencing in Genetics Click to view more details →
Full-Length Transcript Isoform Quantification and Discovery
Enterprise software captures complete transcript sequences and variant isoforms without assembly artifacts, enabling novel biomarker discovery and splice variant-based disease classification for pharmaceutical and biotech companies. Monetization occurs through research licensing, biomarker validation contracts, and drug target identification services.
Long Read Sequencing in Genetics Click to view more details →
Centromeric and Telomeric Region Assembly Validation Service
Specialized sequencing and analysis services resolve previously intractable highly repetitive genomic regions critical for chromosomal stability and aging-related research using long-read technologies. Revenue models include contracted research services, reagent kits, and tiered data analysis subscriptions for genomics research institutions.
Long Read Sequencing in Genetics Click to view more details →
Fragile X Syndrome Molecular Diagnosis
Developing PCR and Southern blot methods for FMR1 repeat sizing and methylation analysis for diagnosing fragile X syndrome in children with ID.
Genetic Basis of Intellectual Disability Click to view more details →
Angelman and Prader-Willi Syndrome Testing
Applying MS-MLPA, methylation-specific PCR, and UBE3A sequencing for molecular diagnosis of Angelman and Prader-Willi imprinting disorders.
Genetic Basis of Intellectual Disability Click to view more details →
Chromatin Disorder Gene Panel for ID
Developing gene panels for chromatin-related intellectual disability syndromes including KAT6A, KDM5C, and MED13L mutations.
Genetic Basis of Intellectual Disability Click to view more details →
Metabolic Cause Identification in ID by WES
Using exome sequencing for identifying metabolic causes of intellectual disability amenable to dietary or pharmacological treatment.
Genetic Basis of Intellectual Disability Click to view more details →
Copy Number Variation Detection Platform for ID Diagnosis
A SaaS platform that identifies pathogenic copy number variations across the genome using advanced algorithms to detect deletions and duplications associated with intellectual disability. This tool enables clinical labs to offer comprehensive CNV testing services, capturing a significant revenue stream from variant interpretation and report generation for pediatric diagnostics.
Genetic Basis of Intellectual Disability Click to view more details →
De Novo Mutation Prediction Engine for Developmental Disorders
An AI-powered software tool that predicts and prioritizes de novo mutations in trio-based whole exome sequencing data to identify novel disease-causing variants in intellectual disability cases. This commercial service generates recurring revenue through licensing fees and interpretation add-ons for genetic testing laboratories and clinical research institutions.
Genetic Basis of Intellectual Disability Click to view more details →